Live
Home·Deals·Healthcare and pharmacy services·Apolo V Acquisition Corp. acquires TelyRx
SEO URLwww.firestrike.ai/deals/telyrx-apolo-v-acquisition-corp-acquisition-2026
acquisitionAnnounced · Feb 20, 2026Healthcare and pharmacy servicesSource · CredibleArticle · Factual
TelyRx
Apolo V Acquisition Corp.
TelyRx · Apolo V Acquisition Corp.

Apolo V Acquisition Corp. acquires TelyRx

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$40M
Target
TelyRx
TelyRx
Acquirer
Apolo V Acquisition Corp.
Apolo V Acquisition Corp.
Merger
Status
Pending

Apolo V Acquisition Corp. agreed to acquire TelyRx. Reported deal value: $40M. Status: Pending. Sector: Healthcare and pharmacy services. Target headquarters context: United States.

This page summarizes publicly available information about the transaction as of 2026-02-20. Figures and status may change as filings and press coverage update.

Apolo V Acquisition Corp . announces it has amended its business combination agreement with TelyRx , Inc. dated January 19, 2026 effected in connection with its previously announced proposed qualifying transaction and postponed its special meeting of shareholders , which had been scheduled to be held on February 19, 2026.Amended Business Combination Agreement The Company, TelyRx , TelyRx Finco Inc., 1001474388 Ontario Inc. and Apolo V MergerCo Inc. entered into an amending agreement dated February 19, 2026, amending the Business Combination Agreement

Deal timeline

Announced
Feb 20, 2026 · marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Healthcare and pharmacy services with a reported deal value of $40M. Figures and status may change as sources update.

Sources: marketscreener.com · Primary article · FireStrike proprietary index